News
News releases on January 4, 2024, page 2
Every news release public companies put out on January 4, 2024 (UTC): 379 news releases, newest first. Open any release to read it.
Diadrom Software Adds Microchip's PIC32CZ CA MCU to Portfolio
Diadrom Holding AB · Jan 4, 2024
Response to ASX Price and Volume Query
Fatfish Group Ltd. · Jan 4, 2024
Faraday Collaborates in Arm Total Design to Provide Arm Neoverse CSS-based Design Services
Faraday Technology Corp. · Jan 4, 2024
Update on Subscription TVR & Investor Presentation
Gana Media Group plc · Jan 4, 2024
Update
Metir plc · Jan 4, 2024
Trading Update
JD Sports Fashion PLC · Jan 4, 2024
Strategic acquisition of Airon Corporation
Inspiration Healthcare Group PLC · Jan 4, 2024
Result of AGM
Amala Foods PLC · Jan 4, 2024
Notice of Capital Markets Event
Avon Technologies PLC · Jan 4, 2024
Holding(s) in Company – TR1 Notification
Serabi Gold PLC · Jan 4, 2024
Fynapse Win
Aptitude Software Group plc · Jan 4, 2024
Fundraise, Board Changes and Operational Update
Landore Resources Limited · Jan 4, 2024
Contract Wins
Shearwater Group plc · Jan 4, 2024
Closing of second round of subscriptions
BWA Group PLC · Jan 4, 2024
Breakthrough clinical results
CelLBxHealth plc · Jan 4, 2024
Board Changes & Business and Strategy Update
Iconic Labs plc · Jan 4, 2024
Arrow Provides Operations Update and 2024 Guidance
Arrow Exploration Corp. · Jan 4, 2024
Appointment of Non-Executive Director
GSTechnologies Ltd. · Jan 4, 2024
Acquisition of US based Single Cask Nation
Artisanal Spirits Company PLC · Jan 4, 2024
Acquisition of Red Box International
LPA Group PLC · Jan 4, 2024
HIVE Digital Increases HODL Position and Provides December 2023 Production and Corporate Update
HIVE Digital Technologies Ltd · Jan 4, 2024
Bendigo-Ophir Exploration and Project Update
Santana Minerals Ltd. · Jan 4, 2024
Ad hoc announcement pursuant to Art. 53 LR - Jungfrau Railway Group - More than 1 million guests visit the Jungfraujoch - Top of Europe
Jungfraubahn Holding AG · Jan 4, 2024
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
Zymeworks Inc. · Jan 4, 2024
Zymeworks Announces Additional Leadership Appointments
Zymeworks Inc. · Jan 4, 2024
Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer
Zevra Therapeutics, Inc. · Jan 4, 2024
XWELL Announces Plans to Open an XpresSpa in THE PENN DISTRICT
XWELL, Inc. · Jan 4, 2024
Xeris Biopharma Updates Its Outlook for 2023
Xeris Biopharma Holdings, Inc. · Jan 4, 2024
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
XBiotech Inc. · Jan 4, 2024
WesBanco, Inc. to Host 2023 Fourth Quarter Earnings Conference Call and Webcast on Wednesday, January 24th
WesBanco, Inc. · Jan 4, 2024
Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors
Werewolf Therapeutics, Inc. · Jan 4, 2024
Wearable Devices Releases Mudra Developer Kit for Its Gesture Control Technology
Wearable Devices Ltd. · Jan 4, 2024
Vuzix to Showcase the Broad Functionality AI Brings to its Industry Leading AR Smart Glasses at CES 2024
Vuzix Corporation · Jan 4, 2024
Voyager Therapeutics Announces Proposed Public Offering
Voyager Therapeutics, Inc. · Jan 4, 2024
Voyager Therapeutics Announces Pricing of Public Offering
Voyager Therapeutics, Inc. · Jan 4, 2024
Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Viridian Therapeutics, Inc. · Jan 4, 2024
Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treat...
Verrica Pharmaceuticals Inc. · Jan 4, 2024
Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) Franchise
Vaxcyte, Inc. · Jan 4, 2024
U.S. Gold to Participate at the 2024 Future Minerals Forum in Riyadh, Saudi Arabia
U.S. Gold Corp. · Jan 4, 2024
UMB Announces Conference Call to Discuss Fourth Quarter and Full-Year 2023 Results
UMB Financial Corporation · Jan 4, 2024
Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years an...
Ultragenyx Pharmaceutical Inc. · Jan 4, 2024
TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress
TScan Therapeutics, Inc. · Jan 4, 2024
Trust Stamp announces a patent filing for a groundbreaking AI-powered facial recognition technology
T Stamp Inc. · Jan 4, 2024
Trimble Announces Connected Climate Exchange, Links Farmers to Companies Looking to Meet Sustainability Commitments
Trimble Inc. · Jan 4, 2024
Trevi Therapeutics Provides Business Updates
Trevi Therapeutics, Inc. · Jan 4, 2024
TransAct Receives U.S. Approval for BOHA! Terminal 2 from Leading QSR
TransAct Technologies Incorporated · Jan 4, 2024
Tradeweb Reports December 2023 Total Trading Volume of $28.9 Trillion and Average Daily Volume of $1.46 Trillion
Tradeweb Markets Inc. · Jan 4, 2024
T-Mobile Delivers Another World’s First with 6-Carrier Aggregation
T-Mobile US, Inc. · Jan 4, 2024
Tiptree Inc. Announces Tax Treatment of 2023 Common Stock Distributions
Tiptree Inc. · Jan 4, 2024
TikTok and Peloton Partner to Drive Accessibility of Fitness and Movement with First-of-Its Kind #TikTokFitness Peloton Hub
Peloton Interactive, Inc. · Jan 4, 2024
The Simply Good Foods Company Reports Fiscal First Quarter 2024 Financial Results and Reaffirms Full Fiscal Year 2024 Net Sales and Adjus...
The Simply Good Foods Company · Jan 4, 2024
The ONE Group Hospitality, Inc. to Participate in Two Upcoming Investor Conferences
The ONE Group Hospitality, Inc. · Jan 4, 2024
The Government of Ecuador Approves Atico Mining’s Concession Extension Until 2049
Atico Mining Corporation · Jan 4, 2024
The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk
Illumina, Inc. · Jan 4, 2024
Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2023 Operating Results
Texas Capital Bancshares, Inc. · Jan 4, 2024
Tetra Tech Wins $24 Million USAID Biodiversity and Ecosystem Conservation Contract
Tetra Tech, Inc. · Jan 4, 2024
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
Terns Pharmaceuticals, Inc. · Jan 4, 2024
Take-Two Interactive Software, Inc. Announces Pricing of Add-On Offering of $350 Million of Senior Notes
Take-Two Interactive Software, Inc. · Jan 4, 2024
Super League to Host Virtual Non-Deal Roadshow Webinar on Wednesday, January 17, 2024, at 11: 00 a.m. Eastern Time
Super League Enterprise, Inc. · Jan 4, 2024
Stran & Company Appoints Ian Thomas Wall as Chief Information Officer
Stran & Company, Inc. · Jan 4, 2024
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Stoke Therapeutics, Inc. · Jan 4, 2024
Standard BioTools Stockholders Approve Merger with SomaLogic
Standard BioTools Inc. · Jan 4, 2024
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
Spruce Biosciences, Inc. · Jan 4, 2024
Spice Up Your Resolutions: Wingstop Declares Dry Rub January a Month of Flavorful Indulgence
Wingstop Inc. · Jan 4, 2024
Sphere 3D Corp. Provides December 2023 Production and Operation Updates
Sphere 3D Corp. · Jan 4, 2024
SoFi Schedules Conference Call to Discuss Q4 2023 & Full Year 2023 Results
SoFi Technologies, Inc. · Jan 4, 2024
SoFi Accelerates Retirements With 2% Match On IRA Contributions
SoFi Technologies, Inc. · Jan 4, 2024
Sitka Gold Prepares Mobilization for Winter Diamond Drilling Program at RC Gold Project, Yukon
Sitka Gold Corp. · Jan 4, 2024
SINTX Technologies significantly strengthens its antipathogenic patent portfolio
SiNtx Technologies, Inc. · Jan 4, 2024
Sinclair Expands Multicast Network Footprint in Top-Ten U.S. DMAs
Sinclair, Inc. · Jan 4, 2024
Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD
Silo Pharma, Inc. · Jan 4, 2024
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
Shattuck Labs, Inc. · Jan 4, 2024
SELLAS Life Sciences Announces Pricing of $9.0 Million Public Offering
SELLAS Life Sciences Group, Inc. · Jan 4, 2024
Scholar Rock Provides Corporate Update and Highlights Priorities for 2024
Scholar Rock Holding Corporation · Jan 4, 2024
SAIC to Support the U.S. Navy’s Hypersonics Advanced Concepts and Strategic Missions Programs
Science Applications International Corporation · Jan 4, 2024
Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado
SHF Holdings, Inc. · Jan 4, 2024
Sacks Parente Golf Appoints Golf Industry Veteran Jane Casanta as Newest Board Member
Newton Golf Company, Inc. · Jan 4, 2024
Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer
Sabra Health Care REIT, Inc. · Jan 4, 2024
Roper Technologies schedules fourth quarter 2023 financial results conference call
Roper Technologies, Inc. · Jan 4, 2024
Rocky Mountain Chocolate Schedules Fiscal Third Quarter 2024 Conference Call for January 11, 2024 at 8: 30 A.M. ET
Rocky Mountain Chocolate Factory, Inc. · Jan 4, 2024
Robinhood Markets, Inc. to Announce Fourth Quarter and Full Year 2023 Results on February 13, 2024
Robinhood Markets, Inc. · Jan 4, 2024
Riot Announces December 2023 Production and Operations Updates
Riot Platforms, Inc. · Jan 4, 2024
Rigetti Announces Public Availability of Ankaa-2 System with a 2.5x Performance Improvement Compared to Previous QPUs
Rigetti Computing, Inc. · Jan 4, 2024
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
Rigel Pharmaceuticals, Inc. · Jan 4, 2024
Rhythm Pharmaceuticals Announces Completion of Screening for Enrollment in Setmelanotide Phase 3 Hypothalamic Obesity Trial and Additiona...
Rhythm Pharmaceuticals, Inc. · Jan 4, 2024
Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640
Rhythm Pharmaceuticals, Inc. · Jan 4, 2024
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
Lifeward Ltd. · Jan 4, 2024
Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
Revolution Medicines, Inc. · Jan 4, 2024
Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones
Reviva Pharmaceuticals Holdings, Inc. · Jan 4, 2024
Renforth Resources Grab Samples 2.76% Copper on Surface at Beaupre Copper Discovery, Road Accessible Near Malartic, Quebec
Renforth Resources Inc · Jan 4, 2024
Relmada Therapeutics Provides Corporate Update
Relmada Therapeutics, Inc. · Jan 4, 2024
Rekor Announces $2.1 Million Contract Expansion with Texas Department of Transportation
Rekor Systems, Inc. · Jan 4, 2024
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Recursion Pharmaceuticals, Inc. · Jan 4, 2024
R&D Day Highlights Kymera’s Immunology Strategy and Emerging Pipeline of Novel, First-in-Class Oral Degraders Addressing Multiple Highly ...
Kymera Therapeutics, Inc. · Jan 4, 2024
Ramaco Chairman and CEO Scheduled to Appear on Sky News on Friday, January 5, and BBC World TV on Wednesday, January 10
Ramaco Resources, Inc. · Jan 4, 2024
Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024
Rallybio Corporation · Jan 4, 2024
Principal Financial Group to hold combined earnings and outlook call
Principal Financial Group Inc · Jan 4, 2024
Portillo’s Inc. to Participate in the 2024 ICR Conference
Portillo's Inc. · Jan 4, 2024
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
PolyPid Ltd. · Jan 4, 2024
Pixelworks X7 Gen 2 Visual Processor Makes Debut in OnePlus Ace 3 Smartphone
Pixelworks, Inc. · Jan 4, 2024